The current study elucidates the contributory role of SMAD3 in NSCLC radioresistance, delineating the mechanism wherein enforced SMAD3 expression activates the ITGA6/PI3K/Akt pathway, thereby intensifying NSCLC radioresistance. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.